Multi-Cancer Early Detection (MCED) Screening in Singapore

Medically reviewed by Dr Amaris Lim, Family Physician · Last reviewed August 2026

Why Consider Early Cancer Screening?

Early detection remains one of the most effective ways to improve cancer survival and treatment outcomes. Singapore has well-established national screening programmes for common cancers such as breast cancer (mammogram), cervical cancer (Pap smear/HPV test), and colorectal cancer (FIT test/ 
colonoscopy). 
 
However, many other cancer types — including pancreatic, liver, ovarian, and stomach cancer — currently have no routine screening pathway in Singapore, and are often only detected once symptoms appear at a later, harder-to-treat stage. Multi-Cancer Early Detection (MCED) screening was developed to help close this gap.

multi-cancer early detection screening singapore

What is Multi-Cancer Early Detection (MCED) Screening?

A newer form of blood-based cancer screening



Single blood test, no fasting required




Non-invasive





Analyses circulating tumour DNA (ctDNA) and other biomarkers released by cancer cells into the blood

Who Should Consider MCED Screening?

MCED screening in Singapore may be suitable for:

    • Adults aged 40 years and above
    • Individuals with a family history of cancer
    • Individuals seeking a more comprehensive cancer screening approach

We recommend discussing your individual risk profile with our family doctors before proceeding.

How Accurate is MCED Screening?

High specificity: ~99%

Less likely to produce false positive results as compared to traditional tumour markers such as CEA and CA 19-9

Relatively high overall sensitivity

SPOT-MAS: ~78%
LucenceINSIGHT: ~81%

Sensitivity refers to the ability to detect a disease when it is present.

The sensitivity of MCED screening tests varies depending on cancer type and stage, and may be lower in very early cancers.

MCED Test Packages & Pricing (SPOT-MAS & LucenceINSIGHT)

LucenceINSIGHT Core SPOT-MAS LucenceINSIGHT 12 LucenceINSIGHT 50
$654.00
(incl GST)
$698.00
(incl GST)
$2158.20
(incl GST)
$4229.20
(incl GST)
Colorectal
Breast
Lung
Liver
Pancreas
Thyroid
Colorectal
Breast
Lung
Liver
Pancreas
Head & Neck Cancers
Stomach
Esophagus
Ovary
Uterus
Colorectal
Lung
Liver
Pancreas
Thyroid
Stomach
Gastrointestinal Stromal Tumour (GIST)
Nasopharyngeal
For Men:
Bladder
Prostate
Kidney
Esophagus
For Women:
Breast
Ovarian
Endometrial
Cervical
Colorectal
Breast
Lung
Liver
Pancreas
Thyroid
Stomach
Esophagus
Gastrointestinal Stromal Tumour (GIST)
Nasopharyngeal
Bladder
Prostate
Kidney
Ovarian
Cervical
Endometrial
Acute Myeloid Leukemia
Hairy Cell Leukemia
Burkitt's Lymphoma
Diffuse Large B-cell Lymphoma
Lymphoplasmacytic Lymphoma
Myeloproliferative Neoplasms
Colorectal Neuroendocrine Tumors
Lung Neuroendocrine Tumors
Stomach Neuroendocrine Tumors
Adrenal Gland Cancer
Adult Wilms Tumor
Biliary Tract
Bone
Skin
Oropharyngeal Cancer
Laryngeal Cancer
Mast Cell Tumor
Salivary Gland Cancer
Small Intestine Cancer
Angiosarcoma
Smooth Muscle Sarcoma
Ovarian Germ Cell & Stromal Tumor
Penile Cancer
Testicular Cancer
Vulvar Cancer

Add-On Packages:

Ct-RNA Boost
(Optional add-on for LucenceINSIGHT 12)
$1090.00
(incl GST)
Enhances sensitivity to detect lung, colorectal and breast cancer.
CardioHemeRisk
$2400.00
(incl GST)
Estimates your risk of heart attacks, strokes and leukemia by detecting age-related blood cell mutations (Clonal Hematopoiesis) linked to inflammation.

Your MCED Screening Journey

1. Pre-screening Doctor Consultation  

    • Discuss your medical background, lifestyle, and family history with our family physician to select the right test panel your risk profile. 

 

2. Quick Blood Test (no fasting required)  

    • A standard blood draw will be performed, no fasting or special preparation is needed for MCED tests. 

3. Lab Analysis  

    • 12 -18 working days 
      Your blood sample undergoes advanced genomic testing in an accredited laboratory, analyzing circulating tumour DNA (ctDNA) signals across target organs. 

4. Doctor Review & Follow-up 

    • Review your results directly with our doctor. If a cancer signal is identified, our team provides immediate guidance and diagnostic referral pathways.   

Limitations of MCED Screening

MCED tests are not diagnostic, and a negative result does not completely exclude the possibility of cancer. MCED screening should not replace recommended cancer screening programmes.

Patients should continue routine screening such as:

Mammogram
(breast cancer)

Pap smear / HPV test
(cervical cancer)

FIT test or colonoscopy
(colorectal cancer)

Book your MCED Screening at Our Clinics across Singapore

SPOT-MAS and LucenceINSIGHT™ cancer screening are currently available at the following branches:  

Book an appointment today to find out more!  

Frequently Asked Questions

No, MCED blood screening (such as SPOT-MAS and LucenceINSIGHT) is currently not covered by MediSave or national subsidy schemes like CHAS or Screen for Life (SFL). National subsidy schemes are currently limited to standard cancer screenings (e.g., mammograms, Pap smears/HPV tests, and FIT stool kits). 

The main differences lie in the number of cancers screened, detection technology, and cost. SPOT-MAS analyzes ctDNA to screen for 10 common cancers, while LucenceINSIGHT uses dual ctDNA/ctRNA technology to detect up to 50 cancer types.

Traditional cancer screening (mammogram, Pap smear, colonoscopy) targets one specific cancer type at a time. MCED screening uses a single blood test to assess risk across multiple cancer types simultaneously, including some cancers without a routine national screening pathway in Singapore. 

MCED screening can complement, but does not replace routine National cancer screenings (like mammograms, Pap/HPV tests, and FIT stool kits.) MCED blood tests serve as an additive layer of protection, screening for signals of other cancers that do not have organ-specific screening, before symptoms appear. 

No fasting is required for an MCED blood test alone, as food intake does not affect ctDNA analysis. However, if paired with a general health screening (like blood glucose or cholesterol), overnight fasting is still required.

Test results typically take 12 to 18 working days from the day of your blood draw. Once your lab report is ready, our doctor will schedule a follow-up consultation to review the findings with you. 

MCED screening is typically recommended once every 1 to 2 years. As cancer risks increase with age, annual or biennial testing helps to pick up signs of cancer at an earlier stage. Our doctors will discuss a suitable screening program with you based on your risk factors and medical history. 

No. MCED screening is a risk-assessment tool, not a diagnostic test. A positive result requires further diagnostic investigation, and a negative result does not completely rule out cancer.

Our family physicians will review your results with you and refer you for appropriate follow-up diagnostic tests to confirm or rule out the finding.